Avivagen Inc.

VIV

CA05382F2026

Fishing & Farming

Delayed Toronto S.E. Other stock markets 08:00:00 05/03/2024 pm IST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2023	Avivagen Inc. Announces New 500 Kg Order for OxC-beta	CI
2023	Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	CI

Avivagen Inc. Secures Order for OxC-beta from AB Vista

August 03, 2022 at 04:00 pm IST

Avivagen Inc. secured a significant order for OxC-beta from AB Vista. The 1.2 tonne order of OxC-beta will be shipped for use in Brazil, where AB Vista is running ongoing trials with several large poultry and cattle producers.

Latest news about Avivagen Inc.

Avivagen Inc. Announces New 500 Kg Order for OxC-beta	17/23/17	CI
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	29/23/29	CI
Avivagen Brief: Announcing several corporate updates, relating to allowances of patents, a waiver of an interest payment on its senior secured debentures and continuation of the strategic review process	01/23/01	MT
Avivagen Secures New Orders for 1.1 Tons of Oxc-Beta Livestock Product	24/23/24	MT
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product	24/23/24	CI
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	06/23/06	CI
Avivagen Reports Increase in Sales to Existing Customer	25/23/25	MT
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer	25/23/25	CI
Avivagen Brief: Announcing "Significant" Increase in Sales to an Existing Customer	25/23/25	MT
Avivagen Launches Strategic Review; Comes After Soaring 50% Yesterday	18/23/18	MT
Avivagen Brief: Announcing Review of Strategic Alternatives	18/23/18	MT
Avivagen Announces Review of Strategic Alternatives	18/23/18	CI
Avivagen Inc. Announces Board Changes	20/23/20	CI
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern	17/23/17	MT
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	17/23/17	CI
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	21/23/21	CI
Avivagen Inc. Auditor Raises 'Going Concern' Doubt	21/23/21	CI
Avivagen Announces Foundational Scientific and Commercial Evidence of Product Published in Peer-Reviewed Journal	19/23/19	MT
Avivagen Details Securities for Service Agreements with CEO and Chief Scientific Officer	23/22/23	MT
Avivagen Inc. announced that it expects to receive CAD 1 million in funding	14/22/14	CI
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	16/22/16	CI
Avivagen Inc. Appoints Ira Levy as Interim CFO	16/22/16	CI
Avivagen Brief: Adds It "Supports Wide-spread Adoption of the Technology around the World"	07/22/07	MT
Avivagen Brief: Says Publication of Scientific Paper on Safety of Oxidized Beta Carotene is a "Milestone on the path to broader regulatory clearance to market and sell OxC-beta Products in the U.S."	07/22/07	MT
Avivagen Brief: Announced Publication of Peer-Reviewed Article in Food and Chemical Toxicology Journal	07/22/07	MT

Chart Avivagen Inc.

Duration

Period

More charts

Company Profile

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Companyâs operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

Sector

Fishing & Farming

Calendar

04/06/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
AVIVAGEN INC.	-.--%	284K
GUANGDONG HAID GROUP CO., LIMITED	+20.93%	11.94B
NEW HOPE LIUHE CO.,LTD.	+2.68%	5.88B
PT CHAROEN POKPHAND INDONESIA TBK	+2.99%	5.41B
CHAROEN POKPHAND FOODS	+5.10%	4.59B
BEIJING DABEINONG TECHNOLOGY GROUP CO.,LTD.	-19.97%	2.73B
AKTIESELSKABET SCHOUW & CO.	+3.80%	1.92B
TANGRENSHEN GROUP CO., LTD	-16.00%	1.21B
FUJIAN TIANMA SCIENCE AND TECHNOLOGY GROUP CO., LTD	-18.65%	948M
WELLHOPE FOODS CO., LTD.	-12.03%	943M

Animal Feed

Avivagen Inc.

Equities

VIV

CA05382F2026

Fishing & Farming

Avivagen Inc. Secures Order for OxC-beta from AB Vista

Latest news about Avivagen Inc.

Chart Avivagen Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Animal Feed